Insider Shareholders with Direct Ownership of Nektar Therapeutics (NKTR)
This section provides a comprehensive overview of the insiders with direct ownership of Nektar Therapeutics (NKTR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NEKTAR THERAPEUTICS Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Howard W Robin
President & CEO |
1,255,875 | 787,813 | 832,080 $981,854 | 28 |
Nov 19, 2024
Reduced 1.92%
|
|
Jillian B. Thomsen
Chief Financial Officer |
303,988 | 163,724 | 313,497 $369,926 | 17 |
Feb 16, 2023
Reduced 3.17%
|
|
Gil M Labrucherie
SVP, COO & CFO |
311,850 | 234,194 | 312,905 $369,227 | 19 |
May 16, 2022
Reduced 5.28%
|
|
R Scott Greer
Director |
117,900 | 0 | 303,574 $358,217 | 5 |
Sep 16, 2022
Added 3.25%
|
| 60,400 | 85,700 | 255,273 $301,222 | 20 |
Jun 14, 2024
Reduced 7.1%
|
|
|
Jonathan Zalevsky
Chief R&D Officer |
292,050 | 330,746 | 243,019 $286,762 | 24 |
Nov 19, 2024
Reduced 3.1%
|
|
John Northcott
SVP & Chief Commercial Officer |
66,350 | 43,140 | 223,210 $263,387 | 8 |
May 16, 2022
Reduced 2.02%
|
|
Mark Andrew Wilson
Chief Legal Officer |
252,388 | 99,609 | 218,856 $258,250 | 22 |
Nov 19, 2024
Reduced 2.84%
|
|
Roy A Whitfield
Director |
60,400 | 81,500 | 216,250 $255,175 | 5 |
Jun 14, 2023
Reduced 12.18%
|
|
Jeffrey Robert Ajer
Director |
20,400 | 15,472 | 34,153 $40,300 | 6 |
Sep 18, 2023
Reduced 11.32%
|
|
Diana Brainard
Director |
28,560 | 0 | 28,560 $33,700 | 2 |
Sep 16, 2022
Added 26.32%
|
|
Myriam Curet
Director |
20,400 | 13,782 | 27,418 $32,353 | 6 |
Sep 18, 2023
Reduced 13.72%
|
|
Karin Eastham
Director |
20,400 | 21,267 | 23,233 $27,414 | 3 |
Sep 16, 2022
Added 30.51%
|